Literature DB >> 15365388

Screening for myopia and refractive errors using LogMAR visual acuity by optometrists and a simplified visual acuity chart by nurses.

Louis Tong1, Seang-Mei Saw, Edwin Shih-Yen Chan, Mabel Yap, Heow-Yong Lee, Yoke-Pin Kwang, Donald Tan.   

Abstract

PURPOSE: To compare the sensitivity and specificity of a widespread method of screening for refractive errors in Singapore schoolchildren using a simplified acuity screening chart with a more rigorous method using the Early Treatment Diabetic Retinopathy Study (ETDRS) chart. A secondary aim is to estimate the best cutoff values for the detection of refractive errors using these two methods.
METHODS: This is a population-based study, involving 1779 schoolchildren from three schools in Singapore. Logarithm of the minimum angle of resolution (logMAR) visual acuity was recorded using a modified Bailey-Lovie chart by trained optometrists, and visual acuity measurement was also undertaken using a simplified 7-line visual acuity screening chart by school health nurses. The main outcome measures were the receiver-operating characteristics (ROC's) of logMAR and the simplified screening visual acuity to detect myopia or any refractive errors. The difference between measurements, simplified screening visual acuity--logMAR visual acuity, was calculated.
RESULTS: The optimal threshold using the simplified screening visual acuity chart for the detection of myopia or any refractive error was 6/12 or worse. Using logMAR visual acuity, the most efficient threshold for the detection of myopia was 0.26, but this was 0.18 for the detection of any refractive error. The area under the ROC curves was significantly greater in the case of the logMAR visual acuity measurement compared with the simplified screening visual acuity measurement for the detection of myopia or any refractive errors. The 95% limits of agreement for the two methods (simplified screening--logMAR acuity) was -0.219 to +0.339.
CONCLUSIONS: Bearing in mind that the visual acuity measurements were performed by two different groups of professionals, visual acuity screening using the ETDRS method appears to be more accurate than the simplified charts for the detection of myopia or any refractive errors in children.

Entities:  

Mesh:

Year:  2004        PMID: 15365388     DOI: 10.1097/01.opx.0000144747.88341.b2

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  5 in total

Review 1.  The cost-effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy.

Authors:  David B Rein; John S Wittenborn; Xinzhi Zhang; Benjamin A Allaire; Michael S Song; Ronald Klein; Jinan B Saaddine
Journal:  Health Serv Res       Date:  2011-04-14       Impact factor: 3.402

2.  The cost-effectiveness of Welcome to Medicare visual acuity screening and a possible alternative welcome to medicare eye evaluation among persons without diagnosed diabetes mellitus.

Authors:  David B Rein; John S Wittenborn; Xinzhi Zhang; Thomas J Hoerger; Ping Zhang; Barbara Eden Kobrin Klein; Kris E Lee; Ronald Klein; Jinan B Saaddine
Journal:  Arch Ophthalmol       Date:  2012-05

3.  Prevalence of uncorrected refractive error and other eye problems among urban and rural school children.

Authors:  Amruta S Padhye; Rajiv Khandekar; Sheetal Dharmadhikari; Kuldeep Dole; Parikshit Gogate; Madan Deshpande
Journal:  Middle East Afr J Ophthalmol       Date:  2009-04

4.  Incidence and progression of myopia and associated factors in urban school children in Delhi: The North India Myopia Study (NIM Study).

Authors:  Rohit Saxena; Praveen Vashist; Radhika Tandon; Ravindra M Pandey; Amit Bhardawaj; Vivek Gupta; Vimala Menon
Journal:  PLoS One       Date:  2017-12-18       Impact factor: 3.240

5.  School-based epidemiology study of myopia in Tianjin, China.

Authors:  Jiaxing Wang; Ying Li; Zhenyang Zhao; Nan Wei; Xiaoli Qi; Gang Ding; Xue Li; Jing Li; Linlin Song; Ying Zhang; Richard Hyun Yi; Yuxian Ning; Xiaoyu Zeng; Ning Hua; Xuehan Qian
Journal:  Int Ophthalmol       Date:  2020-05-29       Impact factor: 2.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.